Grantham, Mayo, Van Otterloo & Co (GMO)’s Arch Capital ACGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
156,236
+39,904
+34% +$3.76M 0.03% 217
2026
Q1
$11.2M Sell
116,332
-43,214
-27% -$4.14M 0.03% 234
2025
Q4
$15.3M Sell
159,546
-16,071
-9% -$1.47M 0.04% 204
2025
Q3
$15.9M Sell
175,617
-29,791
-15% -$2.67M 0.04% 197
2025
Q2
$18.7M Sell
205,408
-173,329
-46% -$16M 0.06% 186
2025
Q1
$36.4M Buy
378,737
+100,927
+36% +$9.31M 0.11% 114
2024
Q4
$25.7M Buy
277,810
+143,094
+106% +$14.4M 0.08% 161
2024
Q3
$15.1M Sell
134,716
-86,160
-39% -$8.96M 0.05% 224
2024
Q2
$22.3M Buy
220,876
+178,629
+423% +$17.4M 0.08% 173
2024
Q1
$3.91M Sell
42,247
-3,127
-7% -$264K 0.01% 319
2023
Q4
$3.37M Buy
45,374
+26,159
+136% +$2.14M 0.01% 313
2023
Q3
$1.53M Buy
+19,215
New +$1.5M 0.01% 426
2022
Q4
Sell
-328,500
Closed -$15M 710
2022
Q3
$15M Sell
328,500
-19,100
-5% -$863K 0.09% 204
2022
Q2
$15.8M Buy
347,600
+319,600
+1,141% +$14.8M 0.09% 208
2022
Q1
$1.36M Buy
+28,000
New +$1.3M 0.01% 488
2020
Q2
Sell
-33,143
Closed -$943K 739
2020
Q1
$943K Buy
+33,143
New +$1.34M 0.01% 504
2016
Q2
Sell
-95,400
Closed -$2.26M 563
2016
Q1
$2.26M Hold
95,400
0.01% 360
2015
Q4
$2.22M Buy
95,400
+900
+1% +$22.1K 0.01% 327
2015
Q3
$2.31M Buy
+94,500
New +$2.21M 0.01% 313
2015
Q1
Sell
-12,480
Closed -$246K 433
2014
Q4
$246K Sell
12,480
-294,540
-96% -$5.59M ﹤0.01% 422
2014
Q3
$5.6M Buy
307,020
+31,620
+11% +$583K 0.01% 258
2014
Q2
$5.27M Sell
275,400
-9,600
-3% -$183K 0.01% 265
2014
Q1
$5.47M Buy
285,000
+17,382
+6% +$322K 0.01% 278
2013
Q4
$5.33M Sell
267,618
-89,118
-25% -$1.71M 0.01% 299
2013
Q3
$6.44M Buy
356,736
+1,140
+0.3% +$20.4K 0.02% 269
2013
Q2
$6.09M Buy
+355,596
New +$6.19M 0.02% 266

Other funds holding ACGL

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACGL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Arch Capital (ACGL) stake by 34% in Q2 2026, buying an estimated $3.76M and bringing the position to 156,236 shares worth $15.2M. The position accounts for 0.03% of the portfolio, ranked #217.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACGL in Q2 2013 and has held it in 26 quarters since. The position peaked at $36.4M in Q1 2025. 906 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 156,236 shares of Arch Capital worth $15.2M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 39,904 Arch Capital shares in Q2 2026, an estimated $3.76M.
  • Arch Capital made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #217 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Arch Capital in Q2 2013 and has held it in 26 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Arch Capital position peaked at $36.4M in Q1 2025.
  • 906 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.